Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1997Transplantation

Disposition of Basiliximab, an Interleukin-2 Receptor Monoclonal Antibody, in Recipients of Mismatched Cadaver Renal Allografts1

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJohn M. KovarikNovartis (Switzerland)PWP. WolfHôpital d'HautepierreJCJ.M. Cisterne

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kovarik et al. (1997) studied this question.

synapsesocial.com/papers/6a98fb5052d74751e81ff8cchttps://doi.org/10.1097/00007890-199712270-00012
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A RANDOMIZED PROSPECTIVE TRIAL OF ANTI-TAC MONOCLONAL ANTIBODY IN HUMAN RENAL TRANSPLANTATION1991 · 180 citations
  2. 2PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATION1995 · 184 citations
  3. 3Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts1990 · 275 citations
  4. 4A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) ADMINISTRATION TO PREVENT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1995 · 65 citations
  5. 5ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN THE TREATMENT OF ONGOING ACUTE REJECTION EPISODES OF HUMAN KIDNEY GRAFT-A PILOT STUDY1989 · 39 citations